Partners Healthcare System in Boston has integrated CT contrast media guidelines into its electronic medical record to encourage physicians to comply with the safety standards and to cut costs for the hospitals in its network.
Partners Healthcare System in Boston has integrated CT contrast media guidelines into its electronic medical record to encourage physicians to comply with the safety standards and to cut costs for the hospitals in its network.
In 2003 Partners' radiology administrative director Kathryn McCullough and members of the Partners CT Contrast Media Team started to assess contrast media administration guidelines and screening procedures for patients at risk for contrast reactions at the system's six hospitals.
After discovering wide variations in policies and procedures, they developed a standard code for contrast media administration plus a patient questionnaire and adverse reaction form, all available through the EMR. The initiative has allowed them to identify patients with a history of prior contrast reactions. The group published its results in the Journal of the American College of Radiology (JACR 2009;6:562-566).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.